Oxygenated environment enhances both stem cell survival and osteogenic differentiation

Area of Science:

• Biomaterials Science
• Stem Cell Biology
• Regenerative Medicine

Background:

• Mesenchymal stem cell (MSC) osteogenesis is oxygen-dependent.
• Perfluorotributylamine (PFTBA), a synthetic oxygen carrier, has shown potential in enhancing bone formation.
• Understanding the mechanism of PFTBA's effect on MSCs is crucial for bone regeneration therapies.

Purpose of the Study:

• To investigate the mechanism by which PFTBA enhances MSC-based bone formation.
• To determine the effect of transient oxygen increase via PFTBA on MSC survival, proliferation, and differentiation.
• To evaluate PFTBA's impact on hypoxia-related gene expression and osteogenic/chondrogenic differentiation.

Main Methods:

• MSCs overexpressing bone morphogenetic protein 2 were encapsulated in alginate beads with or without PFTBA emulsion.
• Oxygen levels were measured over 96 hours.
• Cell viability, proliferation, and gene expression (hypoxia-related, osteogenic, chondrogenic) were assessed.
• Osteogenic and chondrogenic differentiation ratios were analyzed.

Main Results:

• PFTBA supplementation significantly increased available oxygen levels in alginate beads.
• PFTBA-containing beads showed elevated and sustained cell viability with a lower ratio of dead cells.
• Hypoxia-related gene expression (VEGF, DDIT3, PKG1) was significantly downregulated in PFTBA-treated MSCs.
• PFTBA promoted osteogenic differentiation while decreasing chondrogenic differentiation.

Conclusions:

• PFTBA effectively increases oxygen availability for MSCs encapsulated in alginate beads, mitigating hypoxia.
• Enhanced cell survival and reduced hypoxia-related gene expression were observed with PFTBA treatment.
• PFTBA promotes osteogenic differentiation, suggesting its utility in accelerating MSC-based bone regeneration.